HU165181B - - Google Patents

Info

Publication number
HU165181B
HU165181B HUCI1185A HUCI001185A HU165181B HU 165181 B HU165181 B HU 165181B HU CI1185 A HUCI1185 A HU CI1185A HU CI001185 A HUCI001185 A HU CI001185A HU 165181 B HU165181 B HU 165181B
Authority
HU
Hungary
Application number
HUCI1185A
Other languages
Hungarian (hu)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to HUCI1185A priority Critical patent/HU165181B/hu
Priority to DE2252665A priority patent/DE2252665A1/de
Priority to IL40685A priority patent/IL40685A/en
Priority to AT925372A priority patent/AT332531B/de
Priority to DD166641A priority patent/DD100631A1/xx
Priority to GB5049572A priority patent/GB1403900A/en
Priority to SU721846969A priority patent/SU1009467A1/ru
Priority to CA155,789A priority patent/CA978479A/en
Priority to CS727556A priority patent/CS217603B1/cs
Publication of HU165181B publication Critical patent/HU165181B/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08Oxides; Hydroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10Carbonates; Bicarbonates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HUCI1185A 1971-11-08 1971-11-08 HU165181B (es)

Priority Applications (9)

Application Number Priority Date Filing Date Title
HUCI1185A HU165181B (es) 1971-11-08 1971-11-08
DE2252665A DE2252665A1 (de) 1971-11-08 1972-10-27 Nierensteinloesendes praeparat und verfahren zu dessen herstellung
IL40685A IL40685A (en) 1971-11-08 1972-10-27 Pharmaceutical compositions for the dissolution of renal calculi containing magnesium and citrate ions and their preparation
AT925372A AT332531B (de) 1971-11-08 1972-10-31 Verfahren zur herstellung eines nierensteinlosenden praparates
DD166641A DD100631A1 (es) 1971-11-08 1972-11-02
GB5049572A GB1403900A (en) 1971-11-08 1972-11-02 Pharmaceutical composition
SU721846969A SU1009467A1 (ru) 1971-11-08 1972-11-04 Средство дл растворени мочевых конкрементов
CA155,789A CA978479A (en) 1971-11-08 1972-11-07 Composition for the dissolution of renal calculi and process for the preparation thereof
CS727556A CS217603B1 (en) 1971-11-08 1972-11-08 Method of preparing compositions for dissolving renal calculi

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HUCI1185A HU165181B (es) 1971-11-08 1971-11-08

Publications (1)

Publication Number Publication Date
HU165181B true HU165181B (es) 1974-07-27

Family

ID=10994422

Family Applications (1)

Application Number Title Priority Date Filing Date
HUCI1185A HU165181B (es) 1971-11-08 1971-11-08

Country Status (9)

Country Link
AT (1) AT332531B (es)
CA (1) CA978479A (es)
CS (1) CS217603B1 (es)
DD (1) DD100631A1 (es)
DE (1) DE2252665A1 (es)
GB (1) GB1403900A (es)
HU (1) HU165181B (es)
IL (1) IL40685A (es)
SU (1) SU1009467A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3046580A1 (de) * 1980-12-11 1982-07-01 Leskovar, Peter, Dr.-Ing., 8000 München Harnsteinaufloesende mittel
DE3728814A1 (de) * 1987-08-28 1989-03-30 Lentia Gmbh Loesung zur anwendung als spuelfluessigkeit in der zerstoerung von koerperfremden ablagerungen in menschlichen und tierischen geweben oder koerperhohlraeumen
JP2545479B2 (ja) * 1989-02-07 1996-10-16 ミッション ファーマカル カンパニー,インコーポレーテッド 医薬組成物
CA1326040C (en) * 1989-11-16 1994-01-11 Neill B. Walsdorf Magnesium-potassium citrate
DE4409949C2 (de) * 1994-03-23 1996-11-21 Madaus Ag Verwendung von Calcium-Alkalicitraten zur Prophylaxe und Behandlung degenerativer Erkrankungen des Knochengerüstes
DE10028167B4 (de) * 2000-06-09 2004-02-19 Storch, Rüdiger, Dr. Verwendung von Calciumsalzen zur Entgegenwirkung der Bildung von Oxalatharnsteinen
WO2009143021A1 (en) * 2008-05-22 2009-11-26 Bristol-Myers Squibb Company Method for treating and preventing kidney stones employing an sglt2 inhibitor and composition containing same
FR2967576B1 (fr) * 2010-11-18 2013-07-12 Advicenne Pharma Composition pharmaceutique comprenant du sel precurseur du cycle de krebs, en particulier du sel de citrate, et son utilisation comme medicament
FR2967578B1 (fr) 2010-11-18 2012-12-28 Advicenne Pharma Composition pharmaceutique comportant des sels de citrate et de bicarbonate, et son utilisation pour le traitement de la cystinurie
US9278112B2 (en) 2013-03-15 2016-03-08 New York University Citrate containing beverage

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3328304A (en) * 1964-07-31 1967-06-27 Guardian Chemical Corp Chelating agents and methods for their manufacture
FR2019261A1 (en) * 1969-03-19 1970-07-03 Melon Jean Marie Treatment of oxalic lithiase with succinic - acid and its derivs

Also Published As

Publication number Publication date
DE2252665C2 (es) 1987-09-10
IL40685A (en) 1976-08-31
AT332531B (de) 1976-10-11
GB1403900A (en) 1975-08-28
IL40685A0 (en) 1972-12-29
CS217603B1 (en) 1983-01-28
SU1009467A1 (ru) 1983-04-07
DE2252665A1 (de) 1973-05-10
ATA925372A (de) 1976-01-15
DD100631A1 (es) 1973-10-05
CA978479A (en) 1975-11-25

Similar Documents

Publication Publication Date Title
ATA136472A (es)
HU165181B (es)
AR196074A1 (es)
AU459467B2 (es)
JPS5110221B1 (es)
AU2691671A (es)
AU2952271A (es)
AU3005371A (es)
AU2941471A (es)
AU2742671A (es)
AU2684071A (es)
AU2836771A (es)
AU2654071A (es)
AU2927871A (es)
AU2875571A (es)
AU2854371A (es)
AU2684171A (es)
AU2930871A (es)
AU2740271A (es)
AU2938071A (es)
AR192311Q (es)
AU2706571A (es)
AU2473671A (es)
AU2755871A (es)
AU2963771A (es)

Legal Events

Date Code Title Description
HU90 Patent valid on 900628